FEDERATED HERMES, INC. - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 428 filers reported holding REPLIGEN CORP in Q2 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$70,901,446
+11.3%
445,893
-1.0%
0.19%
+19.6%
Q2 2023$63,724,477
-16.0%
450,477
-0.0%
0.16%
-17.3%
Q1 2023$75,873,286
-11.5%
450,661
-11.0%
0.19%
-19.4%
Q4 2022$85,739,769
-8.9%
506,407
+0.7%
0.24%
-14.1%
Q3 2022$94,109,000
+12.5%
502,962
-2.3%
0.28%
+21.6%
Q2 2022$83,627,000
-18.9%
514,944
-6.0%
0.23%
-2.6%
Q1 2022$103,081,000
-30.9%
548,040
-2.6%
0.23%
-15.9%
Q4 2021$149,076,000
-8.4%
562,892
-0.1%
0.28%
-10.6%
Q3 2021$162,831,000
+44.5%
563,450
-0.2%
0.31%
+47.6%
Q2 2021$112,681,000
-9.5%
564,478
-11.9%
0.21%
-13.2%
Q1 2021$124,578,000
-5.8%
640,798
-7.1%
0.24%
-10.4%
Q4 2020$132,214,000
+31.8%
689,945
+1.5%
0.27%
+14.9%
Q3 2020$100,309,000
+18.6%
679,873
-0.7%
0.24%
+12.4%
Q2 2020$84,590,000
+37.4%
684,325
+7.3%
0.21%
+15.5%
Q1 2020$61,580,000
-38.7%
637,876
-41.3%
0.18%
-19.2%
Q4 2019$100,476,000
+14.9%
1,086,230
-4.7%
0.22%
+4.2%
Q3 2019$87,451,000
+2.4%
1,140,323
+14.7%
0.22%
+3.9%
Q2 2019$85,431,000
+52.1%
993,969
+4.6%
0.21%
+48.9%
Q1 2019$56,150,000
+13.0%
950,414
+0.9%
0.14%
+3.0%
Q4 2018$49,670,000
+28.6%
941,773
+35.3%
0.14%
+50.0%
Q3 2018$38,616,000
+0.8%
696,280
-14.5%
0.09%
-19.6%
Q2 2018$38,302,000
+13.7%
814,238
-12.5%
0.11%
+14.3%
Q1 2018$33,682,000
+7.9%
930,956
+8.2%
0.10%
+11.4%
Q4 2017$31,221,000
-2.3%
860,560
+3.2%
0.09%
-4.3%
Q3 2017$31,963,000
-8.7%
834,097
-1.3%
0.09%
-8.9%
Q2 2017$35,009,000
+17.7%
844,789
-0.0%
0.10%
+18.8%
Q1 2017$29,738,000
+14.2%
844,818
-0.0%
0.08%
+9.0%
Q4 2016$26,048,000
+1.9%
845,176
-0.2%
0.08%
+5.4%
Q3 2016$25,565,000
+9.7%
846,815
-0.5%
0.07%
+8.8%
Q2 2016$23,295,000
+0.3%
851,445
-1.7%
0.07%
-5.6%
Q1 2016$23,227,000
+41.8%
866,006
+49.6%
0.07%
+38.5%
Q4 2015$16,377,000
+1.1%
578,908
-0.4%
0.05%0.0%
Q3 2015$16,194,000
-32.1%
581,476
+0.7%
0.05%
-26.8%
Q2 2015$23,838,000
+33.2%
577,611
-2.0%
0.07%
+29.1%
Q1 2015$17,894,000
+37.0%
589,421
-10.6%
0.06%
+37.5%
Q4 2014$13,060,000
-15.0%
659,592
-14.6%
0.04%
-18.4%
Q3 2014$15,372,000
-10.6%
772,095
+2.3%
0.05%
-9.3%
Q2 2014$17,201,000
+66.5%
754,764
-6.1%
0.05%
+54.3%
Q1 2014$10,333,000
+1.1%
803,500
+7.2%
0.04%0.0%
Q4 2013$10,223,000
-37.3%
749,475
-49.0%
0.04%
-44.4%
Q3 2013$16,296,000
-2.9%
1,469,400
-27.8%
0.06%
-4.5%
Q2 2013$16,776,0002,035,8700.07%
Other shareholders
REPLIGEN CORP shareholders Q2 2021
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders